Teva and Samsung Bioepis have launched Epysqli, a cost-saving Soliris biosimilar, offering a 30% discount and new hope for ...

Early market entry, manufacturing efficiency, and market share are critical to biosimilar development success, while technical complexity and competition heavily impact returns, according to a study ...

Affirming that analytical characterization is often sufficient for biosimilar approval, minimizing unnecessary clinical ...

Early market entry, manufacturing efficiency, and market share are critical to biosimilar development success, while ...

Number 5: Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in ...

Will the FTC Be More PBM-Friendly Under a Second Trump Administration?

Will the FTC Be More PBM-Friendly Under a Second Trump Administration?

Will the FTC Be More PBM-Friendly Under a Second Trump Administration?

Will the FTC Be More PBM-Friendly Under a Second Trump Administration?

Will the FTC Be More PBM-Friendly Under a Second Trump Administration?